Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
64,895,756
-
Shares change
-
+2,276,932
-
Total reported value, excl. options
-
$1,045,046,178
-
Value change
-
+$48,610,778
-
Put/Call ratio
-
137%
-
Number of buys
-
79
-
Number of sells
-
-91
-
Price
-
$16.1
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2017
202 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q2 2017.
IMPAX LABORATORIES INC - COM (IPXL) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,895,756 shares
.
Largest 10 shareholders include BlackRock Inc. (10,675,062 shares), MAVERICK CAPITAL LTD (7,159,336 shares), VANGUARD GROUP INC (6,821,118 shares), DIMENSIONAL FUND ADVISORS LP (3,244,580 shares), AMERIPRISE FINANCIAL INC (2,802,813 shares), STATE STREET CORP (2,636,521 shares), CITADEL ADVISORS LLC (2,184,613 shares), Point72 Asset Management, L.P. (1,742,578 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,585,828 shares), and DEUTSCHE BANK AG\ (1,445,977 shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.